Rx（处方）医疗食品市场：按产品类型、治疗用途、分销渠道、地区 - 规模、份额、展望、机会分析，2022-2030 年

医疗食品是一类食品，用于控制特定疾病和医疗状况（例如肺部疾病、胃肠道疾病和代谢紊乱）的饮食控制和预防性治疗。 医疗食品中使用的原材料必须是“公认安全的”(GRAS)。 医疗食品不同于营养食品、膳食补充剂和处方药。 医疗食品以蛋白质、营养成分（omega-3 脂肪酸、螯合锌、异黄酮）为基础，可能含有矿物质和维生素，如叶酸和硫胺素。 这些产品由医生开处方或在医生的监督下服用。 美国食品和药物管理局 (FDA) 将医疗食品分为四大类：营养完全产品、营养不完全产品、代谢紊乱製剂和口服补液溶液。 美国食品和药物管理局 (FDA) 根据孤儿药法案 (1988) 单独监管医疗食品，以确保公共安全并遏制声称可以治癒疾病的产品的存在。我来了。 医用食品不需要上市前批准、研究性新药 (IND) 指定或在 FDA 单独註册。 然而，医疗食品需要通过适当的实验室和临床研究来支持□□所有健康声明。

市场动态

在预测期内，各种监管机构合作等有机战略的兴起预计将推动全球 Rx（处方）医疗食品市场。 例如，2021 年 10 月，印度食品安全与标准局 (FSSAI) 宣布食品加工业部 (MoFPI)、农民生产者组织 (FPO)、微观食品企业家、自助团体 (SHG)和生产者合作社签订了一项协议，以帮助提高其食品业务的标准。 该协议包括食品安全培训和微型企业註册和许可。 FSSAI 和 MoFPI 协助微型企业获得和註册 FSSAI 许可证。

这项研究的主要特点

• 本报告对全球 Rx（处方）医疗食品市场进行了深入分析，显示了以 2021 年为基准年的预测期（2022-2030 年）的市场规模和復合年增长率 (CAGR%) . 提供。
• 它揭示了不同细分市场的潜在收入机会，并为该市场概述了一个有吸引力的投资建议矩阵。
• 它还提供有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采用的竞争策略的重要见解。
• 根据公司亮点、产品组合、关键亮点、绩效和战略等参数介绍全球 Rx 医疗食品市场主要参与者的概况。
• 本研究涵盖的主要公司包括雅培实验室、达能公司、美赞臣公司、费森尤斯卡比公司、雀巢公司、Primus Pharmaceuticals, Inc.、Targeted Medical Pharma Inc.、Pivo□□tal Therapeutics Inc.、VAYA Pharma, Inc.、Lanfam 和 AlfaSigma S.P.A.
• 这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。我猜。
• 《全球 Rx 医疗食品市场报告》针对该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以通过用于分析全球 Rx（处方）医疗食品市场的各种战略矩阵来促进决策制定。

内容

第 1 章目的和先决条件

• 调查目的
• 先决条件
• 缩写说明

第2章市场展望

• 报告内容
  • 市场定义和范围
• 执行摘要
  • 按产品类型划分的市场概况
  • 市场概况：按治疗应用分类
  • 市场概况：按分销渠道
  • 市场概况：按地区
• 连贯机会图 (COM)

第3章市场动态、规律及趋势分析

• 市场动态
  • 司机
  • 约束因素
  • 市场机会
• 影响分析
• 市场趋势
• 近期趋势
• 收购和合作场景
• 技术概览
• 监管情景
• 价格分析
• 害虫分析

第 4 章 Rx（处方）医疗食品的全球市场 - 冠状病毒 (COVID-19) 大流行的影响

• 总体影响
• 政府举措
• COVID-19 对市场的影响

第 5 章全球 Rx（处方）医疗食品市场：按产品类型，2017-2030

• 药丸
• 粉末
• 液体
• 其他（威化饼、咀嚼片、棒状食品）

第 6 章按治疗用途划分的 Rx（处方）医疗食品全球市场：2017-2030

• 疼痛管理
• 神经系统疾病
• 消化系统疾病
• 呼吸系统疾病
• 代谢性疾病
• 其他（纤维化、透析、艾滋病等）

第 7 章全球 Rx（处方）医疗食品市场：按分销渠道，2017-2030

• 零售药房
• 在线药店

第 8 章全球 Rx 医疗食品市场：按地区划分，2017-2030

• 北美
• 美国
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地区
• 欧洲
• 英国
• 德国
• 意大利
• 法国
• 西班牙
• 俄罗斯
• 其他欧洲地区
• 亚太地区
• 中国
• 印度
• 日本
• 东盟
• 澳大利亚
• 韩国
• 其他亚太地区
• 中东
• 海湾合作委员会
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中非
• 南非

第9章竞争格局

• Abbott Laboratories
• Danone S.A.
• Mead Johnson & Company, LLC.
• Fresenius Kabi AG
• Nestle S.A.
• Primus Pharmaceuticals, Inc.
• Targeted Medical Pharma Inc.
• Pivotal Therapeutics Inc.
• VAYA Pharma, Inc.
• Lanfam
• AlfaSigma S.P.A.

第 10 章

• 调查方法
• 关于出版商

Medical food is a category of food products for dietary management or preventive therapy for specific disease or medical conditions such as pulmonary, gastrointestinal, and metabolic disorders. Ingredients used in medical foods must have 'generally recognized as safe' (GRAS) status. Medical food is different from nutritional food, dietary supplements, and prescription drugs. Medical food is protein-based, nutrient-based (Omega 3 fatty acids, chelated zinc, and isoflavones), and may contain minerals and vitamins such as folic acid and thiamine. These products are prescribed by physicians or taken under their supervision. The U.S. Food & Drug Administration (FDA) has classified medical foods into four major categories; nutritionally complete products, nutritionally incomplete products, formulas for metabolic disorders, and oral rehydration solutions. The U.S. Food and Drug Administration separately regulates medical food under Orphan Drug Act (1988) to ensure safety of populace and curb presence of products falsely claiming to cure medical conditions. Medical food does not require premarket approval, specification as an investigational new drug (IND), and individual registration with the FDA. However, they are required to support all their health claims with proper laboratory and clinical studies.

Market Dynamics

Increasing number of organic strategies such as collaboration by the various regulatory authorities is expected to drive the global Rx medical food market over the forecast period. For instance, in October 2021, Food Safety and Standards Authority of India (FSSAI) had signed an agreement with Ministry of Food Processing Industries (MoFPI) to support Farmer Producer Organizations (FPOs), Micro Level Food Entrepreneurs, Self Help Groups (SHGs) and Producers Cooperatives to improve the standards of their food business. This agreement will include food safety training and Registration & License of the Micro Enterprises. FSSAI and MoFPI support micro enterprises for obtaining FSSAI license and registration.

Key features of the study:

• This report provides an in-depth analysis of the global Rx medical food market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global Rx medical food market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Abbott Laboratories, Danone S.A., Mead Johnson & Company, LLC, Fresenius Kabi AG, Nestle S.A., Primus Pharmaceuticals, Inc., Targeted Medical Pharma Inc., Pivotal Therapeutics Inc., VAYA Pharma, Inc., Lanfam and AlfaSigma S.P.A.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global Rx medical food market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Rx medical food market

Detailed Segmentation:

• Global Rx Medical Food Market, By Product Type:
  • Pills
  • Powder
  • Liquid
  • Others (Wafers, Chewable and Bars)
• Global Rx Medical Food Market, By Therapeutic Application:
  • Pain Management
  • Neurological Disorders
  • Gastrointestinal Disorders
  • Pulmonary Disorders
  • Metabolic Disorders
  • Others (Fibrosis, Dialysis, AIDS, etc.)
• Global Rx Medical Food Market, By Distribution Channel:
  • Retail Pharmacies
  • Online Pharmacies
• Global Rx Medical Food Market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Abbott Laboratories*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Danone S.A.
  • Mead Johnson & Company, LLC.
  • Fresenius Kabi AG
  • Nestle S.A.
  • Primus Pharmaceuticals, Inc.
  • Targeted Medical Pharma Inc.
  • Pivotal Therapeutics Inc.
  • VAYA Pharma, Inc.
  • Lanfam
  • AlfaSigma S.P.A.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Therapeutic Application
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Technology Overview
• Regulatory Scenario
• Pricing Analysis
• PEST Analysis

4. Global Rx Medical Food Market - Impact of Coronavirus (Covid-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the market

5. Global Rx Medical Food Market, By Product Type, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Pills
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Powder
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Liquid
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others (Wafers, Chewable, and Bars)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Rx Medical Food Market, By Therapeutic Application, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Pain Management
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Neurological Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Gastrointestinal Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Pulmonary Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Metabolic Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others (Fibrosis, Dialysis, AIDS, etc.)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Rx Medical Food Market, By Distribution Channel, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Rx Medical Food Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Danone S.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Mead Johnson & Company, LLC.
  • Company Highlight
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Fresenius Kabi AG
  • Company Highlight
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Nestle S.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Primus Pharmaceuticals, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Targeted Medical Pharma Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Pivotal Therapeutics Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• VAYA Pharma, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Lanfam
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• AlfaSigma S.P.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Section

• Research Methodology
• About Us